To study the effectiveness of intralesional verapamil in resolution of plaque of peyronie’s disease
Keywords:
penile deformity, intralesional verapamil, erectile dysfunctionAbstract
The prospective study was conducted to study the role of intralesional verapamil in resolution of plaque of peyronies disease. Verapamil's effectiveness is predicated on its ability to affect fibroblast function on multiple levels, including cell proliferation, extracellular matrix protein synthesis and secretion, and collagen breakdown. Calcium antagonists may thus have the potential to reduce, halt, or even reverse plaque formation and Peyronie's disease progression. According to the intralesional verapamil injection therapy, the majority of men with Peyronie's disease who receive treatment experience long-term pain relief, curvature reduction, and enhanced sexual performance. Intralesional verapamil injection therapy resulted in reduction of pain in 92% cases, reduction of plaque size in 80% cases, reduction of penile curvature in 75% cases and improvement in erectile dysfunction in 60% cases.
Downloads
References
Hatzimouratidis K, Eardley I, Giuliano F, Hatzichristou D, Moncada I, Salonia A, Vardi Y, Wespes E. EAU guidelines on penile curvature. Eur Urol 2012; 62: 543-552 [PMID: 22658761 DOI: 10.1016/j.eururo.2012.05.040]
Gonzalez-Cadavid NF, Rajfer J. Mechanisms of Disease: new insights into the cellular and molecular pathology of Peyronie’s disease. Nat Clin Pract Urol 2005; 2: 291-297 [PMID: 16474811 DOI: 10.1038/ncpuro0201]
Rhoden EL, Riedner CE, Fuchs SC, Ribeiro EP, Halmenschlager G. A cross-sectional study for the analysis of clinical, sexual and laboratory conditions associated to Peyronie’s disease. J Sex Med 2010; 7: 1529-1537 [PMID: 19912489 DOI: 10.1111/j.1743-6109.2009.01584.x]
Tal R, Heck M, Teloken P, Siegrist T, Nelson CJ, Mulhall JP. Peyronie’s disease following radical prostatectomy: incidence and predictors. J Sex Med 2010; 7: 1254-1261 [PMID: 20500447 DOI: 10.1111/j.1743-6109.2009.01655.x]
Bekos A, Arvaniti M, Hatzimouratidis K, Moysidis K, Tzortzis V, Hatzichristou D. The natural history of Peyronie’s disease: an ultrasonography-based study. Eur Urol 2008; 53: 644-650 [PMID: 17673362 DOI: 10.1016/j.eururo.2007.07.013]
Ralph DJ, Minhas S. The management of Peyronie’s disease. BJU Int 2004;93:208 15.
Levine LA. Treatment of Peyronie's disease with intralesional verapamil injection. J Urol. 1997 Oct; 158(4):1395-9.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
